7066693
C. botulinum BoNT-D Light Chain Antibody, R&D Systems™
Mouse Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
BoNT-D Light Chain
Concentration
LYOPH
Applications
Western Blot
Conjugate
Unconjugated
Host Species
Mouse
Target Species
C. botulinum
Gene Accession No.
P19321
Isotype
IgG1
Purification Method
Protein A or G purified from hybridoma culture supernatant
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone
695004
Dilution
Western Blot 1 ug/mL
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen
E. coli-derived recombinantC. botulinumBoNT-D Light Chain Thr2-Ser428 Accession # P19321
Primary or Secondary
Primary
Reconstitution
Sterile PBS to a final concentration of 0.5 mg/mL.
Test Specificity
DetectsC. botulinumBoNT-D Light Chain in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant Light Chains of BoNT-A, -B, -C1, -E, -F, -G or recombinant Heavy Chains of BoNT-A, -C1, or -D is observed.
Related Products
Description
- BoNT-D Light Chain Monoclonal specifically detects BoNT-D Light Chain in C
- botulinum samples
- It is validated for Western Blot.
Compare Similar Items
Show Difference
Antigen: BoNT-D Light Chain
Concentration: LYOPH
Applications: Western Blot
Conjugate: Unconjugated
Host Species: Mouse
Target Species: C. botulinum
Gene Accession No.: P19321
Isotype: IgG1
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone: 695004
Dilution: Western Blot 1 ug/mL
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen: E. coli-derived recombinantC. botulinumBoNT-D Light Chain Thr2-Ser428 Accession # P19321
Primary or Secondary: Primary
Reconstitution: Sterile PBS to a final concentration of 0.5 mg/mL.
Test Specificity: DetectsC. botulinumBoNT-D Light Chain in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant Light Chains of BoNT-A, -B, -C1, -E, -F, -G or recombinant Heavy Chains of BoNT-A, -C1, or -D is observed.
Antigen:
BoNT-D Light Chain
Concentration:
LYOPH
Applications:
Western Blot
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
C. botulinum
Gene Accession No.:
P19321
Isotype:
IgG1
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone:
695004
Dilution:
Western Blot 1 ug/mL
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen:
E. coli-derived recombinantC. botulinumBoNT-D Light Chain Thr2-Ser428 Accession # P19321
Primary or Secondary:
Primary
Reconstitution:
Sterile PBS to a final concentration of 0.5 mg/mL.
Test Specificity:
DetectsC. botulinumBoNT-D Light Chain in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant Light Chains of BoNT-A, -B, -C1, -E, -F, -G or recombinant Heavy Chains of BoNT-A, -C1, or -D is observed.
Antigen: CLEC9a
Concentration: __
Applications: Flow Cytometry, CyTOF
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: Q6UXN8
Isotype: IgG1
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone: 683409
Dilution: Flow Cytometry 2.5 ug/10^6 cells, Binding Inhibition 1 ug/mL, CyTOF-ready
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen: Mouse myeloma cell line NS0-derived recombinant human CLEC9a Lys57-Val241 Accession # Q6UXN8
Primary or Secondary: Primary
Reconstitution: Sterile PBS to a final concentration of 0.5 mg/mL.
Test Specificity: Detects human CLEC9a in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) CLEC1, 2, 2A, 3B, 10A, 12B, 14A, rhCD302/CLEC13a, rhMICL, or recombinant mouse CLEC9a is observed.
Antigen:
CLEC9a
Concentration:
__
Applications:
Flow Cytometry, CyTOF
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
Q6UXN8
Isotype:
IgG1
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone:
683409
Dilution:
Flow Cytometry 2.5 ug/10^6 cells, Binding Inhibition 1 ug/mL, CyTOF-ready
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human CLEC9a Lys57-Val241 Accession # Q6UXN8
Primary or Secondary:
Primary
Reconstitution:
Sterile PBS to a final concentration of 0.5 mg/mL.
Test Specificity:
Detects human CLEC9a in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) CLEC1, 2, 2A, 3B, 10A, 12B, 14A, rhCD302/CLEC13a, rhMICL, or recombinant mouse CLEC9a is observed.
Antigen: EphA6
Concentration: __
Applications: Western Blot, Blockade of Receptor-ligand Interaction
Conjugate: Unconjugated
Host Species: Rat
Target Species: Mouse
Gene Accession No.: Q62413
Isotype: IgG1
Purification Method: Protein A or G purified from ascites
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone: 81605
Dilution: Western Blot 1 ug/mL, Blockade of Receptor-ligand Interaction
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse EphA6 Met1-Gln546 Accession # Q62413
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects mouse EphA6 in direct ELISAs and Western blots. In direct ELISAs, approximately 15% cross-reactivity with recombinant rat EphB1 is observed and no cross-reactivity with recombinant human EphA1, A5, recombinant mouse EphA2, A3, A4, A7, A8, B2, B3, B4, or B6 is observed.
Antigen:
EphA6
Concentration:
__
Applications:
Western Blot, Blockade of Receptor-ligand Interaction
Conjugate:
Unconjugated
Host Species:
Rat
Target Species:
Mouse
Gene Accession No.:
Q62413
Isotype:
IgG1
Purification Method:
Protein A or G purified from ascites
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone:
81605
Dilution:
Western Blot 1 ug/mL, Blockade of Receptor-ligand Interaction
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen:
Mouse myeloma cell line NS0-derived recombinant mouse EphA6 Met1-Gln546 Accession # Q62413
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects mouse EphA6 in direct ELISAs and Western blots. In direct ELISAs, approximately 15% cross-reactivity with recombinant rat EphB1 is observed and no cross-reactivity with recombinant human EphA1, A5, recombinant mouse EphA2, A3, A4, A7, A8, B2, B3, B4, or B6 is observed.
Antigen: GFR alpha-2/GDNF R alpha-2
Concentration: __
Applications: Western Blot
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: O00451
Isotype: IgG2b
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone: 129030
Dilution: Western Blot 1 ug/mL
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen: Mouse myeloma cell line NS0-derived recombinant human GFR alpha-2/GDNF R alpha-2 Ser22-Ser441 Accession # O00451
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human GFR alpha-2/GDNF R alpha-2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) GDNF R alpha , rhGFR alpha-3, rhGFRa-4, and recombinant mouse GFR alpha-2 is observed.
Antigen:
GFR alpha-2/GDNF R alpha-2
Concentration:
__
Applications:
Western Blot
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
O00451
Isotype:
IgG2b
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Clone:
129030
Dilution:
Western Blot 1 ug/mL
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human GFR alpha-2/GDNF R alpha-2 Ser22-Ser441 Accession # O00451
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human GFR alpha-2/GDNF R alpha-2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) GDNF R alpha , rhGFR alpha-3, rhGFRa-4, and recombinant mouse GFR alpha-2 is observed.